WO2024074894 - POLYMERIC MICELLE NANOCARRIERS FOR TARGETED EPIDERMAL DELIVERY OF THE HEDGEHOG PATHWAY INHIBITOR TAK-441
National phase entry:
Publication Number
WO/2024/074894
Publication Date
11.04.2024
International Application No.
PCT/IB2023/000608
International Filing Date
03.10.2023
Title **
[English]
POLYMERIC MICELLE NANOCARRIERS FOR TARGETED EPIDERMAL DELIVERY OF THE HEDGEHOG PATHWAY INHIBITOR TAK-441
[French]
NANOVECTEURS DE MICELLES POLYMÈRES POUR L'ADMINISTRATION ÉPIDERMIQUE CIBLÉE DE L'INHIBITEUR DE LA VOIE HEDGEHOG TAK-441
Applicants **
UNIVERSITÉ DE GENÈVE
Inventors
DARADE, Aditya, R.
LAPTEVA, Maria
KALIA, Yogeshvar, N.
Priority Data
63/413,066
04.10.2022
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2992 | |
| EPO | Filing, Examination, Granting | 23482 | |
| Japan | Filing, Examination, Granting | 3089 | |
| South Korea | Filing, Examination, Granting | 3759 | |
| USA | Filing, Examination, Granting | 9540 |
Total:
42,862
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
Micelle compositions comprising a hedgehog pathway inhibitor and their use in treating skin diseases, conditions, or disorders, such as skin cancers, including basal cell carcinoma, are disclosed.[French]
L'invention concerne des compositions de micelles comprenant un inhibiteur de la voie Hedgehog et leur utilisation dans le traitement de maladies, d'affections ou de troubles cutanés, tels que des cancers de la peau, y compris le carcinome basocellulaire.